ARCELLX, INC. ACLX 深 沪
已收盘 08-08 16:00:00 美东时间
70.50
-0.650
-0.91%
华盛通- 最 高74.88
- 今 开70.73
- 成交量 86.77万股
- 最 低 67.8449
- 昨 收 71.15
- 总市值 38.85亿
- 52周最高 107.3699
- 市盈率 静 --
- 换手率 1.57%
- 52周最低 47.8601
- 委 比 -99.91%
- 总股本 5510.67万
- 历史最高 107.3699
- 量 比 1.99
- 振 幅 9.89%
- 历史最低 6.035
- 每 手 1
- 风险率 10.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Arcellx Q2 EPS $(0.94) Beats $(1.05) Estimate, Sales $7.554M Miss $13.617M Estimate
Arcellx (NASDAQ:ACLX) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(1.05) by 10.22 percent. This is a 84.31 percent decrease over losses of $(0.51) per share from the same
08-08 04:41
美股大行评级 | 罕见！Meta、微软连续获多家大行上调目标价；花旗上调Robinhood目标价升至120美元
今日重点评级关注：丰业银行：维持Arcellx"跑赢大市"评级，目标价从93美元升至133美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从89美元升至100美元
08-01 10:17
Scotiabank Maintains Sector Outperform on Arcellx, Raises Price Target to $133
Scotiabank analyst George Farmer maintains Arcellx (NASDAQ:ACLX) with a Sector Outperform and raises the price target from $93 to $133.
08-01 01:54
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment.
06-30 20:36
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
美股大行评级 | 超配！Hinge Health获多家大行首予评级； Oppenheimer上调Mate目标价从665美元升至775美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持SurgePays Inc(SURG)"买入"评级，目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital：维持LiqTech Internatio
06-17 09:46
HC Wainwright & Co. Reiterates Buy on Arcellx, Maintains $115 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates Arcellx (NASDAQ:ACLX) with a Buy and maintains $115 price target.
06-16 19:34
Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling around 300 points on W...
05-21 22:11
Arcellx Announces Positive Phase 2 Study Results
Arcellx Inc ( ($ACLX) ) just unveiled an announcement. On May 14, 2025, Arcellx...
05-14 22:28
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
